Market Place
Sourcing Support
Stallergenes Greer Expands Into Nordic Markets
24 Oct 2024 //
BUSINESSWIRE
FDA Approves Palforzia® Pediatric Indication For Peanut Allergy Treatment
30 Jul 2024 //
BUSINESSWIRE
Stallergenes Greer Food, Respiratory Immunotherapy Data At EAACI
31 May 2024 //
BUSINESSWIRE
Stallergenes Science Award Winners: 2023 Greer Foundation Allergy Research
27 May 2024 //
BUSINESSWIRE
Stallergenes Greer: Sublingual AIT Benefit In Allergic Asthma
02 May 2024 //
BUSINESSWIRE
Stallergenes Greer Announces Publication of Results for PALFORZIA® Phase 3 Study
20 Nov 2023 //
BUSINESSWIRE
Stallergenes Greer Announces Global Agreement With Nestlé
04 Sep 2023 //
BUSINESSWIRE
Stallergenes Greer initiates Phase III study of Staloral Birch
26 May 2023 //
CLINICAL TRIALS ARENA
Positive Results of EfficAPSI Real-World Study Confirm Significant Benefit
02 Jul 2022 //
BUSINESSWIRE
Stallergenes Strengthens Precision Medicine Approach in Allergen Immunotherapy
17 Jan 2022 //
BUSINESSWIRE
Stallergenes Greer Launches CORAP Research Programme
07 Oct 2021 //
BUSINESSWIRE
Stallergenes Greer, Alyatec enter research collaboration
12 Jul 2021 //
PHARMABIZ
Stallergenes Greer Announces that Alustal®
26 Jun 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.